Tilray (NASDAQ:TLRY) Trading Up 3.5%

Shares of Tilray Inc (NASDAQ:TLRY) shot up 3.5% during mid-day trading on Wednesday . The company traded as high as $2.46 and last traded at $2.39. 21,563,917 shares traded hands during trading, a decline of 12% from the average session volume of 24,624,719 shares. The stock had previously closed at $2.31.

Tilray Trading Down 0.4 %

The stock has a fifty day moving average of $1.88 and a 200-day moving average of $2.00. The company has a market cap of $1.83 billion, a PE ratio of -1.11 and a beta of 2.30. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.99 and a current ratio of 1.63.

Insider Transactions at Tilray

In related news, CFO Carl A. Merton purchased 20,000 shares of the business’s stock in a transaction dated Friday, January 12th. The shares were purchased at an average cost of $1.87 per share, for a total transaction of $37,400.00. Following the completion of the acquisition, the chief financial officer now owns 20,000 shares in the company, valued at approximately $37,400. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CEO Irwin D. Simon acquired 53,700 shares of Tilray stock in a transaction on Friday, January 12th. The shares were bought at an average cost of $1.88 per share, for a total transaction of $100,956.00. Following the acquisition, the chief executive officer now directly owns 2,033,058 shares of the company’s stock, valued at approximately $3,822,149.04. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Carl A. Merton bought 20,000 shares of the stock in a transaction on Friday, January 12th. The stock was purchased at an average price of $1.87 per share, with a total value of $37,400.00. Following the completion of the acquisition, the chief financial officer now directly owns 20,000 shares in the company, valued at approximately $37,400. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 96,300 shares of company stock worth $183,210. 0.68% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Tilray

Several institutional investors have recently made changes to their positions in TLRY. Mercer Global Advisors Inc. ADV grew its holdings in Tilray by 10.0% during the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 28,072 shares of the company’s stock worth $77,000 after acquiring an additional 2,550 shares in the last quarter. Rhumbline Advisers lifted its position in shares of Tilray by 20.4% in the 2nd quarter. Rhumbline Advisers now owns 15,464 shares of the company’s stock worth $48,000 after purchasing an additional 2,623 shares during the period. CreativeOne Wealth LLC boosted its stake in shares of Tilray by 8.0% during the third quarter. CreativeOne Wealth LLC now owns 40,591 shares of the company’s stock valued at $112,000 after purchasing an additional 2,994 shares in the last quarter. State of Wyoming increased its holdings in Tilray by 17.0% during the fourth quarter. State of Wyoming now owns 24,561 shares of the company’s stock valued at $66,000 after buying an additional 3,564 shares during the period. Finally, Private Advisor Group LLC raised its stake in Tilray by 6.1% in the second quarter. Private Advisor Group LLC now owns 73,033 shares of the company’s stock worth $114,000 after buying an additional 4,177 shares in the last quarter. Hedge funds and other institutional investors own 9.35% of the company’s stock.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.